Immune Pharmaceuticals Is Really Trying Hard

It’s hard to imagine a 21¢ stock with more going on than Immune Pharmaceuticals. The company is really trying in my opinion. There have clearly been past struggles, but I have no issues with the current strategy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.